weight loss stalled on semaglutide Weight-loss plateau : r/Noom 12 Reasons You're Not Losing

Additionally, real-world pharmacovigilance data highlight sensory adverse events (particularly dysgeusia) that appear more frequently in clinical practice than in controlled trials, suggesting under recognition of taste-related disturbances in research settings (159)

Current guidelines from the American Heart Association and American College of Endocrinology recommend GLP-1 therapy for adults with BMI 27 kg/m and weight-related conditions, or BMI 30 kg/m regardless of comorbidities

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Zepbound, Mounjaro), are not automatically disqualifying medications

Nat Genet